9/30
10:13 am
kala
KALA BIO (NASDAQ:KALA) was downgraded by analysts at Mizuho from an "outperform" rating to a "neutral" rating. They now have a $1.50 price target on the stock.
High
Report
KALA BIO (NASDAQ:KALA) was downgraded by analysts at Mizuho from an "outperform" rating to a "neutral" rating. They now have a $1.50 price target on the stock.
9/30
10:13 am
kala
KALA BIO (NASDAQ:KALA) was downgraded by analysts at Mizuho from an "outperform" rating to a "neutral" rating. They now have a $1.50 price target on the stock.
High
Report
KALA BIO (NASDAQ:KALA) was downgraded by analysts at Mizuho from an "outperform" rating to a "neutral" rating. They now have a $1.50 price target on the stock.
9/30
09:32 am
kala
Kala Bio downgraded to Neutral from Outperform at Mizuho
High
Report
Kala Bio downgraded to Neutral from Outperform at Mizuho
9/30
09:32 am
kala
Kala Bio downgraded to Neutral from Outperform at Mizuho
High
Report
Kala Bio downgraded to Neutral from Outperform at Mizuho
9/11
09:29 am
kala
Rating for KALA
Medium
Report
Rating for KALA
9/11
09:29 am
kala
Rating for KALA
Medium
Report
Rating for KALA
9/8
08:05 am
kala
KALA BIO (NASDAQ:KALA) is now covered by analysts at Mizuho. They set an "outperform" rating and a $30.00 price target on the stock.
Medium
Report
KALA BIO (NASDAQ:KALA) is now covered by analysts at Mizuho. They set an "outperform" rating and a $30.00 price target on the stock.
9/8
08:05 am
kala
KALA BIO (NASDAQ:KALA) is now covered by analysts at Mizuho. They set an "outperform" rating and a $30.00 price target on the stock.
Medium
Report
KALA BIO (NASDAQ:KALA) is now covered by analysts at Mizuho. They set an "outperform" rating and a $30.00 price target on the stock.
9/8
07:41 am
kala
Rating for KALA
High
Report
Rating for KALA
9/8
07:41 am
kala
Rating for KALA
High
Report
Rating for KALA
9/8
05:41 am
kala
Kala Pharmaceuticals initiated with an Outperform at Mizuho
Medium
Report
Kala Pharmaceuticals initiated with an Outperform at Mizuho
9/8
05:41 am
kala
Kala Pharmaceuticals initiated with an Outperform at Mizuho
Medium
Report
Kala Pharmaceuticals initiated with an Outperform at Mizuho